Mahmoud Al Rifai Selected Research

Mahmoud Al Rifai Research Topics

Disease

23	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2015
15	Atherosclerosis 01/2022 - 04/2015
10	Hypertension (High Blood Pressure) 01/2022 - 01/2017
9	Heart Failure 01/2022 - 11/2017
6	Myocardial Infarction 03/2022 - 11/2017
6	Inflammation (Inflammations) 11/2021 - 03/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2016
4	Diabetes Mellitus 01/2022 - 12/2018
4	Obesity 01/2022 - 04/2015
4	Coronary Disease (Coronary Heart Disease) 01/2021 - 06/2015
4	Hemorrhage 01/2021 - 01/2016
3	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2021
3	Chronic Renal Insufficiency 01/2022 - 10/2021
3	Acute Coronary Syndrome 10/2021 - 11/2019
3	COVID-19 03/2021 - 10/2020
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 10/2020
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2021 - 04/2015
2	Infections 03/2021 - 10/2020
2	Atrial Fibrillation 01/2021 - 01/2021
2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Fibrosis (Cirrhosis) 11/2021
1	Premature Menopause 10/2021
1	Human Influenza (Influenza) 03/2021
1	Hypertriglyceridemia 01/2021
1	Isolated Systolic Hypertension 01/2021
1	Pancreatitis 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Hypercholesterolemia 01/2021
1	Homozygous Familial Hypercholesterolemia 01/2020
1	Genetic Risk Score 01/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020
1	Weight Loss (Weight Reduction) 11/2019
1	Peripheral Arterial Disease 01/2019
1	Transient Ischemic Attack 12/2017
1	Stroke (Strokes) 12/2017
1	Cardiomyopathies (Cardiomyopathy) 08/2017

Drug/Important Bio-Agent (IBA)

21	CalciumIBA 01/2022 - 04/2015
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2018
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2016
5	LipidsIBA 01/2022 - 01/2019
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2016
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 01/2020
4	C-Reactive ProteinIBA 01/2017 - 03/2015
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 11/2017
3	dapagliflozinIBA 10/2021 - 01/2019
3	evinacumabIBA 01/2021 - 01/2020
3	LDL CholesterolIBA 01/2020 - 01/2018
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 12/2018
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2022
2	SodiumIBA 01/2022 - 01/2022
2	empagliflozinIBA 10/2021 - 10/2020
2	evolocumabIBA 10/2021 - 11/2019
2	CholesterolIBA 10/2021 - 01/2019
2	Troponin T (Troponin T1)IBA 01/2021 - 01/2017
2	eicosapentaenoic acid ethyl esterIBA 10/2020 - 01/2020
2	alirocumabIBA 01/2020 - 11/2019
2	oxidized low density lipoproteinIBA 01/2020 - 01/2018
2	Fibrinogen (Factor I)FDA Link 01/2017 - 03/2015
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Galectin 3 (LGALS3)IBA 11/2021
1	LectinsIBA 11/2021
1	RivaroxabanIBA 10/2021
1	Proprotein Convertase 9IBA 10/2021
1	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Docosahexaenoic AcidsIBA 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Natriuretic PeptidesIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Carboxylic AcidsIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Eicosapentaenoic AcidIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	vupanorsenIBA 10/2020
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	Colchicine FDA LinkGeneric 10/2020
1	Angiotensin Receptor AntagonistsIBA 10/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	vericiguatIBA 01/2020
1	AdipokinesIBA 01/2018
1	SeleniumIBA 08/2017

Therapy/Procedure

11	Therapeutics 10/2021 - 01/2016
4	Percutaneous Coronary Intervention 01/2022 - 01/2021
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 10/2021
3	Secondary Prevention 01/2020 - 10/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 03/2016
1	Cardiac Rehabilitation 03/2022
1	Braces 10/2020
1	Denervation 01/2020
1	Glycemic Control 11/2019